Medical Condition News

RSS

APHON receives prestigious Gold Award in Association TRENDS' 2011 All-Media Contest

APHON has been honored with a Gold in Educational Program in Association TRENDS' 2011 All-Media Contest. It was one of more than 450 entries in the association publications contest.

12 Jan 2012

Exposure to light appears to have therapeutic effects on Alzheimer's patients

Exposure to light appears to have therapeutic effects on Alzheimer's disease patients, a Wayne State University researcher has found.

12 Jan 2012

$Patients with hip fractures should be operated on within 48 hours of admission$

Patients with hip fractures should be operated on within 48 hours of admission

All patients with hip fractures should be fast-tracked through hospital emergency departments and operated on within 48 hours of admission, according to new consensus guidelines developed by UK experts in anaesthesia, orthopaedics, geriatrics and emergency medicine and published in the January issue of Anaesthesia.

12 Jan 2012

Consuming adequate quantities of dietary fiber can improve health

We should all be eating more dietary fiber to improve our health - that's the message from a health review by scientists in India. The team has looked at research conducted into dietary fiber during the last few decades across the globe and now suggests that to avoid initial problems, such as intestinal gas and loose stool, it is best to increase intake gradually and to spread high-fiber foods out throughout the day, at meals and snacks.

12 Jan 2012

Elevated ISG15 pathway may provide therapeutic targets for breast cancer

Interferon-stimulated gene 15 (ISG15), a ubiquitin like protein, is highly elevated in a variety of cancers including breast cancer. How the elevated ISG15 pathway contributes to tumorigenic phenotypes remains unclear and is the subject of a study published in the January 2012 issue of Experimental Biology and Medicine.

12 Jan 2012

Amarantus receives U.S. patent titled, 'Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof'

Amarantus BioSciences, Inc., a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced U.S. Patent Number 8,084,425 has been issued for MANF entitled, Dopaminergic Neuronal Survival-Promoting Factors and Uses Thereof.

12 Jan 2012

New imaging agent shows promise in detecting signs of AD

Scientists are reporting development and initial laboratory tests of an imaging agent that shows promise for detecting the tell-tale signs of Alzheimer's disease (AD) in the brain - signs that now can't confirm a diagnosis until after patients have died.

12 Jan 2012

Novel avenues to treat heart attack

Novel avenues to treat a heart attack: in patients, who have a blood pressure cuff several times briefly inflated before they undergo coronary artery surgery with cardiopulmonary bypass, the heart is protected from damage.

12 Jan 2012

Chemotherapy drugs can lead to relapse of leukemia

The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest.

12 Jan 2012

UBM Medica's cancer care reference book now available online

UBM Medica's widely acclaimed and trusted cancer care reference book Cancer Management: A Multidisciplinary Approach, 14th edition, is now available online. This guide is designed to present important clinical information concisely, uniformly, and logically, emphasizing the natural history of the malignancy, screening and diagnosis, staging and prognosis, and treatment of cancers.

12 Jan 2012

FDA clears Roche's Accu-Chek Nano SmartView blood glucose monitoring system

Roche announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Accu-Chek Nano SmartView blood glucose monitoring system.

12 Jan 2012

DBS safe and effective for patients with advanced Parkinson's

Researchers from the University of Florida and 14 additional medical centers reported results today in the online version of The Lancet Neurology journal indicating that deep brain stimulation - also known as DBS - is effective at improving motor symptoms and quality of life in patients with advanced Parkinson's disease.

12 Jan 2012

Scientists explain why coffee drinkers show lower risk of Type 2 diabetes

Why do heavy coffee drinkers have a lower risk of developing Type 2 diabetes, a disease on the increase around the world that can lead to serious health problems? Scientists are offering a new solution to that long-standing mystery in a report in ACS' Journal of Agricultural & Food Chemistry.

12 Jan 2012

Link between pacemaker-detected atrial arrhythmias and stroke

An irregular heartbeat that you don't even feel but can be picked up by a pacemaker is associated with a significantly increased risk of stroke, says a new McMaster University study.

12 Jan 2012

Omega-3 can protect nerves from injury and help them to regenerate

Research from Queen Mary, University of London suggests that omega-3 fatty acids, which are found in fish oil, have the potential to protect nerves from injury and help them to regenerate.

12 Jan 2012

USPTO issues patent to Unigene's peptide-based therapeutics for obesity

Unigene Laboratories, Inc., a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that it had been granted U.S. Patent No. 8,076,291 from the United States Patent and Trademark Office.

11 Jan 2012

Nicotine patches may help individuals with early memory loss

Star Scientific, Inc. - A study released in the January 9th issue of the Journal of Neurology suggests that nicotine patches may help individuals with early memory loss.

11 Jan 2012

Spherix completes SPX-106 28-day rat toxicology study

Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported the successful completion of its 28-day rat toxicology study of its drug candidate, SPX-106.

11 Jan 2012

Research into ground-breaking treatment for bowel cancer

Research into a ground-breaking treatment for bowel cancer at Queen's University Belfast has received a massive funding boost from Cancer Research UK.

11 Jan 2012

$Merrimack commences MM-151 Phase 1 trial in refractory advanced solid tumors$

Merrimack commences MM-151 Phase 1 trial in refractory advanced solid tumors

Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 1 clinical trial of MM-151, an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor.

11 Jan 2012